Pfizer Chief Scientific Officer: Pandemic Over, Threat Exaggerated, No 2nd Wave, Many Have T-Cell Immunity
|David DeGraw||Sep 17, 2020||8||2|
In this video, Big Pharma insider Dr. Michael Yeadon is speaking out; confirming what I and many others have been reporting, such as:
✅ The pandemic is fundamentally over;
✅ Science clearly indicates that there will not be a second wave;
✅ Many people have T-cell immunity;
✅ COVID-19 PCR tests are scientifically fraudulent;
✅ There are 10 times more false positives than actual positives;
✅ Lockdowns are deliberately based on unscientific, completely fake data;
✅ COVID-19 threat has been greatly exaggerated;
✅ Lockdowns led to tens of thousands of avoidable deaths.
[You can also watch this video on Facebook here.]
Read my extensive report on all of this and the suppression of effective treatments, which is now censored from Google:
In that report, I provide links to over 100 sources, including many research papers, scientific studies, clinical trials and real-world success stories.
The evidence is now overwhelming! You have to be willfully blind to still believe the "official" COVID narrative.
As Dr. Yeadon also makes clear, “It is obvious to any biological expert that the pandemic is fundamentally over!”
It's time to resume our lives and hold people accountable for Crimes Against Humanity!!
Dr. Yeadon's Bio:
Dr. Michael Yeadon is an Allergy & Respiratory Therapeutic Area expert with 23 years in the pharmaceutical industry. He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988.
Dr. Yeadon then worked at the Wellcome Research Labs with Salvador Moncada with a research focus on airway hyper-responsiveness and effects of pollutants including ozone and working in drug discovery of 5-LO, COX, PAF, NO and lung inflammation. With colleagues, he was the first to detect exhaled NO in animals and later to induce NOS in lung via allergic triggers.
Joining Pfizer in 1995, he was responsible for the growth and portfolio delivery of the Allergy & Respiratory pipeline within the company. He was responsible for target selection and the progress into humans of new molecules, leading teams of up to 200 staff across all disciplines and won an Achievement Award for productivity in 2008.
Under his leadership the research unit invented oral and inhaled NCEs which delivered multiple positive clinical proofs of concept in asthma, allergic rhinitis and COPD. He led productive collaborations such as with Rigel Pharmaceuticals (SYK inhibitors) and was involved in the licensing of Spiriva and acquisition of the Meridica (inhaler device) company.
Dr. Yeadon has published over 40 original research articles and now consults and partners with a number of biotechnology companies. Before working with Apellis, Dr. Yeadon was VP and Chief Scientific Officer (Allergy & Respiratory Research) with Pfizer.
I am working with a small group of people who are volunteering their time to help investigate & publish the most vital info on these quickly unfolding issues. To be blunt, it has been an absolute battle and I have taken on far too much personal debt to get this far. We need your support to continue reporting.
Please consider donating here.
Every dollar seriously helps.
Much Gratitude & Love to All,
~ David DeGraw